This study defines an endocytic trafficking pathway regulated by FCHSD2 and Rab7 that controls receptor tyrosine kinase expression and oncogenic signal transduction, opening the possibility of novel therapeutic strategies for cancer. The gene discussed is RAB7A; the disease is cancer.